NASDAQ:BCYC | Insider Transactions — Page 4 | BICYCLE THERAPEUTICS PLC

BCYC Insider Transactions — Page 4

322 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 301–322; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Cambridge Innovation Capital (Jersey) LtdTenPercentOwner2019-05-29Purchase314,286.0$14.0
TYBOURNE CAPITAL MANAGEMENT (HK) LTDTenPercentOwner2019-05-28Purchase364,286.0$14.0
Tybourne Kesari LtdTenPercentOwner2019-05-28Purchase364,286.0$14.0
Tybourne Capital Management LtdTenPercentOwner2019-05-28Purchase364,286.0$14.0
Krishnan ViswanathanTenPercentOwner2019-05-28Purchase364,286.0$14.0
AQUILA INVESTMENTS IVTenPercentOwner2019-05-28Purchase364,286.0$14.0
NOVARTIS AGTenPercentOwner2019-05-28Purchase168,630.0$14.0
Novartis Bioventures LtdTenPercentOwner2019-05-28Purchase168,630.0$14.0
SV LIFE SCIENCES FUND V LPTenPercentOwner2019-05-28Purchase7,983.0$14.0
SV Life Sciences Fund V Strategic Partners, L.P.TenPercentOwner2019-05-28Purchase7,983.0$14.0
SV Life Sciences Fund V (GP), LPTenPercentOwner2019-05-28Purchase7,983.0$14.0
SVLSF V, LLCTenPercentOwner2019-05-28Purchase7,983.0$14.0
SV LIFE SCIENCES FUND V LPTenPercentOwner2019-05-28Purchase377,732.0$14.0
SV Life Sciences Fund V Strategic Partners, L.P.TenPercentOwner2019-05-28Purchase377,732.0$14.0
SV Life Sciences Fund V (GP), LPTenPercentOwner2019-05-28Purchase377,732.0$14.0
SVLSF V, LLCTenPercentOwner2019-05-28Purchase377,732.0$14.0
Anstey MichaelDirector2019-05-28Purchase314,286.0$14.0
BINGHAM KATEDirector2019-05-28Purchase7,983.0$14.0
BINGHAM KATEDirector2019-05-28Purchase377,732.0$14.0
HARLAND DEBORAHDirector2019-05-28Purchase385,714.0$14.0
GLAXOSMITHKLINE PLCDirector,TenPercentOwner2019-05-28Purchase385,714.0$14.0
NG CAROLYNDirector2019-05-27Purchase571,429.0$14.0